This translocation forms the fusion oncoprotein, a constitutionally active tyrosine kinase BCR-ABL, which has been causatively linked to the development of Chronic Myelogenous Leukemia (CML). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.